Literature DB >> 11887852

High glucose dialysis solutions increase synthesis of vascular endothelial growth factors by peritoneal vascular endothelial cells.

M J Seo1, S J Oh, S I Kim, K W Cho, I Jo, T Schaub, H Schilling, J Passlick-Deetjen, D C Han.   

Abstract

OBJECTIVE: Increased peritoneal vasculature has been reported in long-term peritoneal dialysis (PD), and vascular endothelial growth factors (VEGFs) have been found in dialysate. High concentrations of glucose or lactate, glucose degradation products (GDPs), and low pH of dialysis solutions are all possible factors in increased peritoneal VEGF synthesis. In this study, we investigated the effects of high glucose dialysis solutions on VEGF synthesis by peritoneal vascular endothelial cells (PVECs).
METHODS: The PVECs were isolated from rat omentum and were incubated for 4 hours in three different culture media [M199 media (control), conventional dialysis solutions containing 4.25% glucose diluted with an equal volume of M199 media (HGD), and M199 media containing 118 mmol/L mannitol as an osmolar control (mannitol)]. Levels of VEGF protein in the culture supernatant were measured by ELISA, and mRNA expression was determined by Northern blot analysis. Data are presented as percent of control.
RESULTS: After incubation for 4 hours, the number of cells did not differ between the 3 groups. Levels of VEGF in culture supernatant were significantly higher in the HGD group (124% +/- 19%, p = 0.006) as compared with the control and mannitol (85% +/- 10%) groups. The mRNA expression of VEGF appeared to be higher in the HGD group (128% +/- 49%) than in the control and mannitol (94% +/- 18%) groups.
CONCLUSION: High glucose dialysis solutions increased VEGF synthesis by PVECs. The relationship between VEGF synthesis by PVECs and neovascularization of the peritoneum observed in long-term peritoneal dialysis patients has to be studied further.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11887852

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  7 in total

Review 1.  Pharmacologic targets and peritoneal membrane remodeling.

Authors:  Karima Farhat; Andrea W D Stavenuiter; Rob H J Beelen; Piet M Ter Wee
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

2.  Impaired leptin activity in New Zealand Obese mice: model of angiogenesis.

Authors:  Lukasz Wator; Urszula Razny; Adriana Balwierz; Anna Polus; Hans G Joost; Grzegorz Dyduch; Romana Tomaszewska; Aldona Dembinska-Kiec
Journal:  Genes Nutr       Date:  2008-11-26       Impact factor: 5.523

Review 3.  The Role of Tyrosine Kinase Receptors in Peritoneal Fibrosis.

Authors:  Li Wang; Shougang Zhuang
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

4.  Targeting Src attenuates peritoneal fibrosis and inhibits the epithelial to mesenchymal transition.

Authors:  Jun Wang; Li Wang; Liuqing Xu; Yingfeng Shi; Feng Liu; Hualin Qi; Na Liu; Shougang Zhuang
Journal:  Oncotarget       Date:  2017-08-08

5.  Scavenging of reactive oxygen species by astaxanthin inhibits epithelial-mesenchymal transition in high glucose-stimulated mesothelial cells.

Authors:  Kazuaki Hara; Chieko Hamada; Keiichi Wakabayashi; Reo Kanda; Kayo Kaneko; Satoshi Horikoshi; Yasuhiko Tomino; Yusuke Suzuki
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

Review 6.  Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells.

Authors:  Susan Yung; Tak Mao Chan
Journal:  Mediators Inflamm       Date:  2012-04-10       Impact factor: 4.711

7.  Angiogenesis in the New Zealand obese mouse model fed with high fat diet.

Authors:  Adriana Balwierz; Anna Polus; Urszula Razny; Lukasz Wator; Grzegorz Dyduch; Romana Tomaszewska; Stephan Scherneck; Hans Joost; Aldona Dembinska-Kiec
Journal:  Lipids Health Dis       Date:  2009-04-06       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.